P.23 Work to prevent paracetamol-related intentional drug overdose

Work in 2022 included: the preparation of enhanced signage and messaging for point-of-sale areas and retail staff (in pharmacy, and non-pharmacy retail settings); preparation for a national survey of key stakeholders, and covert market surveillance completed by the HPRA with the retail sector. The survey (to determine levels of awareness of paracetamol sales regulations) and dissemination of associated awareness materials, will take place in 2023.